AAV Assembled Capsids Are Produced in Cells Blocked From Cell Cycle Progression

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• Adeno-associated virus (AAV) is a key vector for gene therapy.
• Current AAV manufacturing yields are low, leading to high costs and limited patient access.
• A significant portion of transfected cells fail to produce AAV capsids.

Purpose of the Study:

• To investigate why some cells transfected with AAV DNA do not produce assembled capsids.
• To characterize the differences between AAV-producing and non-producing cell populations.
• To identify molecular targets for improving AAV production efficiency.

Main Methods:

• Cellular characterization of transfected HEK293 cells.
• Cell cycle analysis of producer and non-producer populations.
• RNA sequencing (RNA-seq) to compare gene expression profiles.

Main Results:

• AAV-producing cells exhibited a distinct cell cycle arrest compared to non-producers.
• RNA-seq revealed significant differences in molecular pathways between the two cell populations.
• These molecular differences provide insights into factors limiting AAV capsid assembly.

Conclusions:

• Cell cycle progression is a critical factor influencing AAV production in transfected cells.
• Understanding the molecular basis of this block can guide strategies to enhance AAV manufacturing yields.
• Targeting cell cycle regulation may overcome limitations in current gene therapy vector production.